Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 802 of 1,261

  1. US 8784791

    Method for preparing water-soluble polymer derivatives bearing an N-succinimidyl ester

    Nektar Therapeutics · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  2. US 8784817

    Method for killing IL-1 alpha expressing cells

    XBIOTECH INC. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  3. US 8785476

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  4. US 8785633

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  5. US 8785487

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  6. US 8785492

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  7. US 8784802

    Ischemic tissue cell therapy

    Cryopraxis Criobiologia Ltda. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  8. US 8784849

    Hydroxyapatite-targeting poly(ethylene glycol) and related polymers

    Nektar Therapeutics · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  9. US 8785661

    Oligome-containing pyrrolidine compounds

    Nektar Therapeutics · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  10. US 8785609

    Cloning and expression of HTLV-III DNA

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  11. US 8785601

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  12. US 8785499

    Targeting NAD biosynthesis in bacterial pathogens

    The Board of Regents of the University of Texas System · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  13. US 8785514

    Dual-cure dental resins and adhesives with increased cure and color stability and low color

    The Board of Regents of the University of Texas System · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  14. US 8785491

    Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  15. US 8785505

    Toxicology and cellular effect of manufactured nanomaterials

    The Regents of the University of California · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  16. US 8785444

    Thiazoles and pyrazoles useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  17. US 8785414

    Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  18. US 8785393

    Ophthalmic pharmaceutical compositions of DP2 receptor antagonists

    Panmira Pharmaceuticals, LLC · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  19. US 8785191

    Concentration of stem cells obtained during orthopaedic surgeries

    UNIVERSITY OF CONNECTICUT · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  20. US 8785460

    Tricyclic compounds and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  21. US 8785429

    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK

    Takeda Pharmaceutical Company Limited · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  22. US 8785486

    Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

    Addex Pharma, S.A. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  23. US 8784866

    Water-soluble carbon nanotube compositions for drug delivery and medicinal applications

    The Board of Regents of the University of Texas System · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  24. US 8785168

    Formulations for lysosomal enzymes

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.